NPS Pharma (NPSP) Expects To File Hypoparathyroidism Therapy BLA In Mid-2013
NPS Pharmaceuticals Inc. (NASDAQ:NPSP) said it expects to submit its Biologic License Application (BLA) for Natpara -- recombinant human parathyroid hormone or rhPTH-(1-84) -- in mid-2013 to treat hypoparathyroidism. [More...]
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here